Precision NanoSystems Inc. (PNI) is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.


Team Members

Lloyd Jeffs Headshot (C)

Lloyd Jeffs

Director, Clinical Manufacturing Solutions

Martin Rabel Headshot (D)

Martin Rebel

Field Application Scientist

Jennifer Griffin Headshot (E)

Jennifer Griffin

Director of Clinical Commercial Operations